Green Eyes is a founder-owned lab technology company that specializes in real-time, field-based nutrient analysis.

The market for leveraged buyouts showed signs of recovery this morning as Goldman Sachs launched a $4.5 billion debt deal ...

"The announcement on our January earnings call of the intention to sell part of our stake in the business has generated ...

China's state-backed funds are pulling back from investing in the funds of U.S.-headquartered private capital firms amid an ...